New medicines must be approved as safe, efficacious and of good quality before they can be prescribed. But authors of two recent articles in the British Medical Journal argue that governments should introduce…
Academic rigour, journalistic flair
Articles on Food and Drug Administration (FDA)
Displaying 161 - 163 of 163 articles
The US Food and Drug Administration (FDA) recently revised the safety labels for statins, widely used anti-cholesterol drugs. They mandated label warnings saying statins may increase the risk of type 2…
The US Food and Drug Administration (FDA), has just issued a warning letter about the safety of CSL’s influenza vaccine, Fluvax. The letter follows FDA’s latest annual inspection of CSL laboratories and…
Top contributors
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Law, Villanova School of Law
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Associate Professor of Pharmacy and Therapeutics, University of Pittsburgh
-
Associate Professor of Obstetrics, Gynecology and Gynecologic Surgery, University of California, San Francisco
-
Associate Professor of Legal Studies and Political Science, UMass Amherst
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Professor and Dean, School of Public Health, Georgia State University
-
Instructor of Human Immunology, Emory University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Associate Professor of Pediatrics, University of Virginia
-
Clinical Associate Professor of Pharmacy Practice, Binghamton University, State University of New York
-
Associate Professor of Operations and Decision Technologies, Kelley School of Business, Indiana University
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Professor of Law, George Washington University
